Search research articles
Contact Us
Filters
Showing results (161-170 of 171) with videos related to
Page
of 18
Sort By:
Molecular and Cellular Biology
|
May 31, 2012
Histone methyltransferase NSD2/MMSET mediates constitutive NF-κB signaling for cancer cell proliferation, survival, and tumor growth via a feed-forward loop
Ping Yang, Linlang Guo, Zhijian J Duan, et al.
Cell Death and Differentiation
|
September 10, 2016
Silencing the epigenetic silencer KDM4A for TRAIL and DR5 simultaneous induction and antitumor therapy
Junjian Wang, Haibin Wang, Ling-Yu Wang, et al.
International Journal of Molecular Sciences
|
December 11, 2022
Microglia-Derived Olfactomedin-like 3 Is a Potent Angiogenic Factor in Primary Mouse Brain Endothelial Cells: A Novel Target for Glioblastoma
Laila M Joseph, Ryan G Toedebusch, Eshetu Debebe, et al.
Cancer Research
|
June 22, 2012
Definition of genetic events directing the development of distinct types of brain tumors from postnatal neural stem/progenitor cells
Falk Hertwig, Katharina Meyer, Sebastian Braun, et al.
Molecular Cancer Therapeutics
|
January 28, 2022
Olaparib-Induced Senescence Is Bypassed through G2-M Checkpoint Override in Olaparib-Resistant Prostate Cancer
Alan P Lombard, Cameron M Armstrong, Leandro S D'Abronzo, et al.
Science Translational Medicine
|
October 9, 2015
Companion animals: Translational scientist's new best friends
Amir Kol, Boaz Arzi, Kyriacos A Athanasiou, et al.
Plos One
|
April 6, 2012
MicroRNA let-7c is downregulated in prostate cancer and suppresses prostate cancer growth
Nagalakshmi Nadiminty, Ramakumar Tummala, Wei Lou, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 9, 2024
Functional inversion of circadian regulator REV-ERBα leads to tumorigenic gene reprogramming
Yatian Yang, Xiong Zhang, Demin Cai, et al.
The Journal of Clinical Investigation
|
March 17, 2026
Targeting Wnt/β-Catenin and circadian regulator restores PRC2/EZH2 controlled chromatin bivalency and suppresses cell state diversity
Yatian Yang, Xiong Zhang, Varadha Balaji Venkadakrishnan, et al.
Nature Communications
|
October 13, 2019
RORγ is a targetable master regulator of cholesterol biosynthesis in a cancer subtype
Demin Cai, Junjian Wang, Bei Gao, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 171) with videos related to
Sort By:
Page
of 18
Molecular and Cellular Biology
|
May 31, 2012
Histone methyltransferase NSD2/MMSET mediates constitutive NF-κB signaling for cancer cell proliferation, survival, and tumor growth via a feed-forward loop
Ping Yang, Linlang Guo, Zhijian J Duan, et al.
Cell Death and Differentiation
|
September 10, 2016
Silencing the epigenetic silencer KDM4A for TRAIL and DR5 simultaneous induction and antitumor therapy
Junjian Wang, Haibin Wang, Ling-Yu Wang, et al.
International Journal of Molecular Sciences
|
December 11, 2022
Microglia-Derived Olfactomedin-like 3 Is a Potent Angiogenic Factor in Primary Mouse Brain Endothelial Cells: A Novel Target for Glioblastoma
Laila M Joseph, Ryan G Toedebusch, Eshetu Debebe, et al.
Cancer Research
|
June 22, 2012
Definition of genetic events directing the development of distinct types of brain tumors from postnatal neural stem/progenitor cells
Falk Hertwig, Katharina Meyer, Sebastian Braun, et al.
Molecular Cancer Therapeutics
|
January 28, 2022
Olaparib-Induced Senescence Is Bypassed through G2-M Checkpoint Override in Olaparib-Resistant Prostate Cancer
Alan P Lombard, Cameron M Armstrong, Leandro S D'Abronzo, et al.
Science Translational Medicine
|
October 9, 2015
Companion animals: Translational scientist's new best friends
Amir Kol, Boaz Arzi, Kyriacos A Athanasiou, et al.
Plos One
|
April 6, 2012
MicroRNA let-7c is downregulated in prostate cancer and suppresses prostate cancer growth
Nagalakshmi Nadiminty, Ramakumar Tummala, Wei Lou, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 9, 2024
Functional inversion of circadian regulator REV-ERBα leads to tumorigenic gene reprogramming
Yatian Yang, Xiong Zhang, Demin Cai, et al.
The Journal of Clinical Investigation
|
March 17, 2026
Targeting Wnt/β-Catenin and circadian regulator restores PRC2/EZH2 controlled chromatin bivalency and suppresses cell state diversity
Yatian Yang, Xiong Zhang, Varadha Balaji Venkadakrishnan, et al.
Nature Communications
|
October 13, 2019
RORγ is a targetable master regulator of cholesterol biosynthesis in a cancer subtype
Demin Cai, Junjian Wang, Bei Gao, et al.
Page
of 18